WebLIMC The wealth of ancient myths and legends which we call Classical Mythology is one of the major elements of our cultural heritage. A huge amount of documents and photographs were assembled in the course of the preparation of the Lexicon Iconographicum Mythologiae Classicae (LIMC; 1981-1999 and 2009) and the Thesaurus Cultus et Rituum Antiquorum (ThesCRA; 2004-2014). This dataset is ...
One of Lancaster Inter-Municipal Committee's largest municipalities soon will no longer be a part of the organization. East Hempfield supervisors have voted to withdraw their township from the LIMC, a ...
Seeking Alpha: Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
THE WOODLANDS, Texas, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (LXRX) (Nasdaq: LXRX) today announced that the Company has submitted additional clinical data to the U.S. Food ...
Lexicon Pharmaceuticals Announces Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
Lexicon expects delay in FDA feedback on additional data for its diabetes drug Lexicon Pharmaceuticals said on Monday the U.S. Food and Drug Administration requires more time to review the company's ...
Seeking Alpha: Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
Discovered using Lexicon’s unique approach to gene science, sotagliflozin is an oral inhibitor of two proteins responsible for glucose regulation known as sodium-glucose cotransporter types 2 and 1 ...
Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes